CSIMarket


Apogee Therapeutics Inc   (NASDAQ: APGE)
Other Ticker:  
 

Apogee Therapeutics Inc

APGE's Fundamental analysis








Apogee Therapeutics Inc 's sales fell in the second quarter of 2025 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 1.92 %

Apogee Therapeutics Inc net loss increased from $-34 millions, to $-66 millions in second quarter of 2025,

More on APGE's Growth


Apogee Therapeutics Inc
realized a net loss in trailing twelve months.

Apogee Therapeutics Inc realized cash reduction of $ -3.13 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.04.


More on APGE's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) -

Apogee Therapeutics Inc
realized net loss in trailing twelve months.

Apogee Therapeutics Inc realized cash outflow of $ -3.13per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.04.


More on APGE's Valuation

  Market Capitalization (Millions $) 3,176
  Shares Outstanding (Millions) 58
  Employees 10
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -238
  Cash Flow (TTM) (Millions $) -183
  Capital Exp. (TTM) (Millions $) -6
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) -

  Market Capitalization (Millions $) 3,176
  Shares Outstanding (Millions) 58
  Employees 10
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -238
  Cash Flow (TTM) (Millions $) -183
  Capital Exp. (TTM) (Millions $) -6





  Ratio
   Capital Ratio (MRQ) 16.36
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) -
  Inventory Turnover Ratio (TTM) -





Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.